Literature DB >> 31270181

Antibodies to Borrelia turicatae in Experimentally Infected Dogs Cross-React with Borrelia burgdorferi Serologic Assays.

Jenna R Gettings1, Job E Lopez2,3, Aparna Krishnavahjala2, Brittany A Armstrong3, Alec T Thompson4, Michael J Yabsley4,5.   

Abstract

Tick-borne relapsing fever (TBRF) is caused by several Borrelia spp. (including Borrelia turicatae), which are primarily transmitted by Ornithodoros ticks. Relapsing fever group species are found worldwide, except for Antarctica. Approximately 500 human cases were reported between 1990 and 2011 in the United States (likely an underestimate), while cases in domestic and wild dogs were reported from Florida, Texas, and Washington. TBRF spirochetes are related to Borrelia burgdorferi, the agent of Lyme borreliosis. Dogs are routinely screened for B. burgdorferi, but it is unknown if infection with TBRF agents produces antibodies cross-reactive with B. burgdorferi assays. These data are critical for accurate surveillance of TBRF and Lyme borreliosis in dogs. In this study, B. burgdorferi-negative dogs were inoculated with B. turicatae, and seroconversion was confirmed by the rBipA (recombinant Borrelia immunogenic protein A) Western blot. Seropositive samples were tested with commercial and veterinary diagnostic laboratory B. burgdorferi-based tests. Borrelia turicatae-seroreactive samples cross-reacted with a whole-cell indirect fluorescent antibody (IFA) test and two multiantigen tests, but not with single-antigen tests using C6. Cross-reactivity with TBRF can confound epidemiology and surveillance efforts and confuse recommendations made by veterinarians for prevention and control. These findings demonstrate the need to critically evaluate results from B. burgdorferi diagnostic tests in the context of the assay type and the animal's geographical location and history of travel, as well as highlighting the need for commercially available specific diagnostic tests for TBRF spirochetes.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Borrelia burgdorferizzm321990; Borrelia turicataezzm321990; Lyme borreliosis; tick-borne relapsing fever

Mesh:

Substances:

Year:  2019        PMID: 31270181      PMCID: PMC6711897          DOI: 10.1128/JCM.00628-19

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

1.  Antigenic conservation of an immunodominant invariable region of the VlsE lipoprotein among European pathogenic genospecies of Borrelia burgdorferi SL.

Authors:  F T Liang; E Aberer; M Cinco; L Gern; C M Hu; Y N Lobet; M Ruscio; P E Voet; V E Weynants; M T Philipp
Journal:  J Infect Dis       Date:  2000-10-09       Impact factor: 5.226

2.  Evaluation of the recombinant VlsE-based liaison chemiluminescence immunoassay for detection of Borrelia burgdorferi and diagnosis of Lyme disease.

Authors:  Thomas B Ledue; Marilyn F Collins; John Young; Martin E Schriefer
Journal:  Clin Vaccine Immunol       Date:  2008-10-22

3.  Performance of a commercially available in-clinic ELISA for detection of antibodies against Anaplasma phagocytophilum, Anaplasma platys, Borrelia burgdorferi, Ehrlichia canis, and Ehrlichia ewingii and Dirofilaria immitis antigen in dogs.

Authors:  Brett A Stillman; Michael Monn; Jiayou Liu; Brendon Thatcher; Paulette Foster; Blaine Andrews; Susan Little; Matt Eberts; Edward B Breitschwerdt; Melissa J Beall; Ramaswamy Chandrashekar
Journal:  J Am Vet Med Assoc       Date:  2014-07-01       Impact factor: 1.936

4.  Phylogenetic analysis of the spirochetes Borrelia parkeri and Borrelia turicatae and the potential for tick-borne relapsing fever in Florida.

Authors:  Tom G Schwan; Sandra J Raffel; Merry E Schrumpf; Paul F Policastro; Julie A Rawlings; Robert S Lane; Edward B Breitschwerdt; Stephen F Porcella
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

5.  First isolation of the relapsing fever spirochete, Borrelia hermsii, from a domestic dog.

Authors:  Ashley L Kelly; Sandra J Raffel; Robert J Fischer; Michael Bellinghausen; Connie Stevenson; Tom G Schwan
Journal:  Ticks Tick Borne Dis       Date:  2013-11-16       Impact factor: 3.744

6.  Evidence of Borrelia lonestari DNA in Amblyomma americanum (Acari: Ixodidae) removed from humans.

Authors:  Ellen Y Stromdahl; Phillip C Williamson; Thomas M Kollars; Sandra R Evans; Ryan K Barry; Mary A Vince; Nicole A Dobbs
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

7.  A phylogenomic and molecular marker based proposal for the division of the genus Borrelia into two genera: the emended genus Borrelia containing only the members of the relapsing fever Borrelia, and the genus Borreliella gen. nov. containing the members of the Lyme disease Borrelia (Borrelia burgdorferi sensu lato complex).

Authors:  Mobolaji Adeolu; Radhey S Gupta
Journal:  Antonie Van Leeuwenhoek       Date:  2014-04-18       Impact factor: 2.271

8.  Spirochetemia caused by Borrelia turicatae infection in 3 dogs in Texas.

Authors:  Marlyn S Whitney; Tom G Schwan; Katherine B Sultemeier; Polly S McDonald; Martin N Brillhart
Journal:  Vet Clin Pathol       Date:  2007-06       Impact factor: 1.180

9.  Sequence analysis and serological responses against Borrelia turicatae BipA, a putative species-specific antigen.

Authors:  Job E Lopez; Hannah K Wilder; William Boyle; L Brock Drumheller; Justin A Thornton; Bridget Willeford; Timothy W Morgan; Andrea Varela-Stokes
Journal:  PLoS Negl Trop Dis       Date:  2013-09-19

10.  Canine infection with Dirofilaria immitis, Borrelia burgdorferi, Anaplasma spp., and Ehrlichia spp. in the United States, 2010-2012.

Authors:  Susan E Little; Melissa J Beall; Dwight D Bowman; Ramaswamy Chandrashekar; John Stamaris
Journal:  Parasit Vectors       Date:  2014-05-30       Impact factor: 3.876

View more
  7 in total

1.  Characterization of Immunological Responses to Borrelia Immunogenic Protein A (BipA), a Species-Specific Antigen for North American Tick-Borne Relapsing Fever.

Authors:  Michael W Curtis; Aparna Krishnavajhala; Alexander R Kneubehl; Monica E Embers; Jenna R Gettings; Michael J Yabsley; Job E Lopez
Journal:  Microbiol Spectr       Date:  2022-05-17

2.  Detection of Lassa Virus-Reactive IgG Antibodies in Wild Rodents: Validation of a Capture Enzyme-Linked Immunological Assay.

Authors:  Hugo Soubrier; Umaru Bangura; Chris Hoffmann; Ayodeji Olayemi; Adetunji Samuel Adesina; Stephan Günther; Lisa Oestereich; Elisabeth Fichet-Calvet
Journal:  Viruses       Date:  2022-05-07       Impact factor: 5.818

Review 3.  Historical overview and update on relapsing fever group Borrelia in Latin America.

Authors:  Álvaro A Faccini-Martínez; Carlos Ramiro Silva-Ramos; Adriana M Santodomingo; Alejandro Ramírez-Hernández; Francisco B Costa; Marcelo B Labruna; Sebastián Muñoz-Leal
Journal:  Parasit Vectors       Date:  2022-06-08       Impact factor: 4.047

Review 4.  Pathogenesis of Relapsing Fever.

Authors:  Job Lopez; Joppe W Hovius; Sven Bergström
Journal:  Curr Issues Mol Biol       Date:  2020-12-29       Impact factor: 2.081

5.  Host Bloodmeal Identification in Cave-Dwelling Ornithodoros turicata Dugès (Ixodida: Argasidae), Texas, USA.

Authors:  Rachel E Busselman; Mark F Olson; Viridiana Martinez; Edward Davila; Cierra Briggs; Devon S Eldridge; Bailee Higgins; Brittany Bass; Thomas L Cropper; Theresa M Casey; Theresa Edwards; Pete D Teel; Sarah A Hamer; Gabriel L Hamer
Journal:  Front Vet Sci       Date:  2021-02-15

6.  Trends in canine seroprevalence to Borrelia burgdorferi and Anaplasma spp. in the eastern USA, 2010-2017.

Authors:  Bhagya Galkissa Dewage; Susan Little; Mark Payton; Melissa Beall; Jennifer Braff; Donald Szlosek; Jesse Buch; Andrew Knupp
Journal:  Parasit Vectors       Date:  2019-10-14       Impact factor: 3.876

7.  Serological prevalence of six vector-borne pathogens in dogs presented for elective ovariohysterectomy or castration in the South central region of Texas.

Authors:  J Mack Fudge; Bailey Boyanowski; Bernie Page; Shuling Liu; Artem S Rogovskyy
Journal:  BMC Vet Res       Date:  2020-10-08       Impact factor: 2.741

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.